Sun Jiulong laughed and said to Xiao Yan: "Young Master Xiao is indeed very knowledgeable. I hope you will remember to bring me with you when you are ready to go to the tomb. Don't forget me. I will show you local reports from other places and they have been blocked."

Sun Jiulong took out two pieces of paper, and Xiao Yan and I took one to look at it.

"On August 6, the reporter's investigation team announced the progress of the investigation into the case of Changsheng Group's illegal production of rabies vaccines.

The investigation team introduced that since April 2014, Changsheng Group has seriously violated the relevant provisions of drug production quality management standards and Imperial Drug Standards during the production of rabies vaccines. Some of its batches are mixed with expired stock solution, and the date and batch number are not truthfully filled in, and some batches are marked with production dates backwards. At present, the recall work is in progress. The vaccines involved in the case sold abroad have also started notification and recall work.

In addition, according to the official website of the National Health Commission, the National Health Commission Committee attached great importance to the recent reports of "Shangluo children vaccination problems" on the Internet, and the committee leaders quickly issued instructions. On August 5, the Imperial Health Commission sent an investigation team to carry out on-site inspection work.

Events pass

Shangluo children vaccination is accused of expired

On the afternoon of August 3, netizens posted a post "Vaccine is fierce! Shaanxi Shangluo found that many children were vaccinated with expired vaccines, and the number of people is still increasing." A parent in Shangluo, Shaanxi found that the muced squirts her child were actually expired vaccines. She panicked and asked in the group. Soon more parents discovered that from 2015 to the present, their children were vaccinated with expired vaccines.

The vaccine provided by this parent is originally the vaccination date of the Mist Esperm vaccine on March 1, 2018. After querying, the results showed that the effective date of the vaccine was July 14, 2017, which means that the vaccine received by the child was expired."

"Kantai Bio announced on the evening of the 5th that it plans to amend the company's articles of association and re-elect directors, and will vote at the extraordinary general meeting of shareholders on August 21.

The announcement stated that the above modification is a "company's business development need", but judging from the new board of directors, the modification may be related to Changsheng Group. Ma Dongguang, one of the retired directors, has served as independent directors of Changsheng Biotechnology and Kangtai Biotechnology since 2015 and 2016 to the present.

Another director Yuan Liping is the wife of Du Weimin, the actual controller of Kangtai Bio. Previously, Changsheng Group caused a storm due to the vaccine incident. Kangtai Chairman Du Weimin once worked at Changsheng Group and was responsible for sales business. Previously, there were doubts on the Internet about whether the two were related. Due to this incident, Kangtai Bio fell to the limit for three consecutive days. Kangtai Bio closed at 46.01 yuan on the latest trading day, a drop of 4.15%.

The change of directors was not a big deal, but it is currently at the "juncture" of Changsheng Bio's investigation, which inevitably makes people suspicious. Kangtai Bio responded that this was a normal change of leadership and had nothing to do with other companies.

The following is the full text:

As Changsheng Group is under investigation, Kangtai Bio seems to have been implicated.

On the evening of August 5, Kangtai Biologics (300601.SZ) announced that it plans to amend the company's articles of association and will vote at the extraordinary general meeting of shareholders on August 21. According to the provisions of the Company Law, amending the company's articles of association must be approved by more than two-thirds of the shareholders' meeting.

The focus of this revision is: a newly established vice chairman assists the chairman in performing his duties. If the chairman is unable to perform his duties or fails to perform his duties, the vice chairman shall be replaced. In addition, the number of people on the board of directors has also been changed from 7 to 5, including 2 independent directors, 1 chairman and 1 vice chairman. According to Article 112 of the Company Law, the board of directors of a joint-stock company should be 5-19, and 5 people are the lower limit stipulated by law.

Public information shows that the management team led by Du Weimin started office in September 2015. According to the provisions of the company's articles of association, it has come to the time for the board of directors to change its term. The board of directors nominated Du Weimin, Zheng Haifa, and Liu Jiankai as non-independent director candidates, Li Xiangming and Luo Danglun as independent director candidates.

The announcement stated that the above modification is a "company's business development need", but judging from the new board of directors, the modification may be related to Changsheng Bio. The change of directors was not a big deal, but with the decrease in the number of board members, the position of vice chairman was newly established, and it is currently at the "juncture" of Changsheng Bio's investigation, which inevitably makes people suspicious.

After the number of board members decreases, two directors will retire: Yuan Liping and Ma Dongguang. Among them, Yuan Liping is the wife of Du Weimin, the actual controller of the company. He is not currently in the company. Ma Dongguang is also an independent director of Changsheng Bio in the vortex.

The public resume shows that Yuan Liping has served as the manager of the audit department of Minhai Biotechnology (the predecessor of Kangtai Biotechnology) since 2010, and the deputy general manager of Kangtai Biotechnology. Since May 2011, she has served as a director of the company. The spouse of the actual controller has been eliminated from the board of directors. Combined with the above-mentioned newly established deputy director as the "spare tire" of the chairman, Kangtai Biotechnology does not seem to be smooth.

Another independent director who resigned has a great background: Ma Dongguang has served as independent directors of Changsheng Biotechnology and Kangtai Biotechnology since 2015 and 2016. In addition, Ma Dongguang has been in the state drug regulatory department for a long time, served as the China Pharmaceutical Biotechnology Inspection Institute and the Drug Supervision Office of the Ministry of Health. From 1996 to 2011, he served as the chief technician of the drug GMP certification center for drug GMP certification at the National Drug Certification Management Center from 1996 to 2011.

Public information shows that the National Drug Certification Management Center is a direct unit of the National Drug Administration, and is responsible for participating in the formulation of the "Drug Production Quality Management Specifications" (GMP), conducting on-site inspections, tracking and supervising spot checks on drugs and enterprises applying for GMP certification. On the official website of the National Drug Administration, Interface News reporters found that Ma Dongguang was hired as a National Drug GMP inspector in 2003 and 2009.

GMP is a set of mandatory standards suitable for pharmaceutical, food and other industries. Companies that have not obtained drug GMP certification cannot obtain the "Pharmaceutical Manufacturing Enterprise License" and cannot produce new drugs. At present, the State Food and Drug Administration has requested the recovery of Changsheng Bio's "Pharmaceutical GMP Certificate" (Certificate No.: JL20180024).

According to the latest announcement of ST Changsheng, 18 criminal suspects involved in Changsheng Bio have been requested for approval for arrest on suspicion of producing and selling inferior drugs. Among them, the directors and senior management personnel are Gao Junfang (Chairman), Zhang Jing (Director), Zhang Youkui, Liu Jingye, Jiang Qianghua, Zhao Zhiwei and Ma Dongguang are not listed.

Public information shows that Kangtai Chairman Du Weimin once worked at Changsheng Bio and was responsible for sales business. Previously, there were doubts on the Internet about whether the two were related. Affected by the Changsheng Bio vaccine incident, Kangtai Bio had hit the limit for three consecutive days. On the latest trading day, Kangtai Bio closed at 46.01 yuan, a drop of 4.15%.

Lawyer Xu Feng from Shanghai Chuangyuan Law Firm told Interface News reporters that according to the "Guiding Opinions on Establishing an Independent Director System in Listed Companies" issued by the China Securities Regulatory Commission in 2001, independent directors shall perform their duties independently and shall not be affected by the major shareholders, actual controllers, or other units or individuals with interests in listed companies. According to the "Guidelines for Standardized Operation of Listed Companies on the GEM Listed Companies on the Shenzhen Stock Exchange", if they are subject to administrative penalties for the China Securities Regulatory Commission in the past three years, they shall not be allowed to serve as directors of the company. That is, once the director is found to have committed illegal acts and is punished, they will not be able to serve as independent directors.

According to China.com Finance on the 6th, on the same day, the reporter called the secretary of the board of directors of Kangtai Bio and the securities affairs representative. As of press time, no one answered the phone number. Then the reporter left a message through the Shenzhen Stock Exchange interactive platform. Kangtai Bio replied that this is a normal change of directors of the company and has nothing to do with other companies. The company's board of directors submitted a list of candidates for the new directors based on the nomination situation and the willingness of individuals to be re-elected. "This change of term is a routine change of term. The company's new director candidates are all members of the previous board of directors. This change of term will not affect the company's operations."

Regarding the questioning why the directors were changed from 7 to 5, Kangtai Bio explained that in this election of the board of directors, some independent directors will no longer be re-elected, resulting in the proportion of independent directors of the company accounting for less than one-third of all members of the board of directors, which does not comply with the provisions of the "Guiding Opinions on Establishing an Independent Director System in Listed Companies". In order to improve decision-making efficiency, the company has adjusted the number of board members."

I was puzzled by what company Kangtai Bio is? What is its relationship with Changsheng Group? Sun Jiulong quickly realized that I was very confused, so he explained to me: "Kantai Bio is the company behind Changsheng Group. Although the Empire has investigated, it has not taken action. Because Kangtai Bio is the headquarters of a cult organization, the Empire will not be able to deal with them for a while. This is the most important clue I found."

Xiao Yan and I were very surprised. It seemed that even Xiao Yan was not very clear about this. I didn’t expect that these two companies were so big, and fake vaccines were used to harm so many children. They were simply not humans, but they were both cultivators, so why did they still make so much money? What is the purpose of building such a large company? Are you developing something?

Xiao Yan said anxiously: "It's broken. These two companies are not just for making money. I'm afraid that these vaccines have problems. They may use these vaccines to control children in the entire empire. Although this is just a guess, it is true that the signs are all."
Chapter completed!